561 reports of this reaction
3.5% of all BENZOYL PEROXIDE reports
#8 most reported adverse reaction
SKIN EXFOLIATION is the #8 most commonly reported adverse reaction for BENZOYL PEROXIDE, manufactured by Alchemee, LLC. There are 561 FDA adverse event reports linking BENZOYL PEROXIDE to SKIN EXFOLIATION. This represents approximately 3.5% of all 15,861 adverse event reports for this drug.
Patients taking BENZOYL PEROXIDE who experience skin exfoliation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SKIN EXFOLIATION is moderately reported among BENZOYL PEROXIDE users, representing a notable but not dominant share of adverse events.
In addition to skin exfoliation, the following adverse reactions have been reported for BENZOYL PEROXIDE:
The following drugs have also been linked to skin exfoliation in FDA adverse event reports:
SKIN EXFOLIATION has been reported as an adverse event in 561 FDA reports for BENZOYL PEROXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SKIN EXFOLIATION accounts for approximately 3.5% of all adverse event reports for BENZOYL PEROXIDE, making it a notable side effect.
If you experience skin exfoliation while taking BENZOYL PEROXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.